Drug · DIN 02148757
DIFFERIN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 8, 2003; first marketed August 8, 2001.
- Drug Identification Number (DIN)
- 02148757
- Company (DIN owner)
- Galderma Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Liquid
- Route
- Topical
- Therapeutic class (ATC)
- Adapalene D10AD03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ADAPALENE | 0.1 % |
Other DINs named DIFFERIN
- DIN 02148749 · Marketed
- DIN 02231592 · Marketed
- DIN 02376660 · Approved